New president at Cardinal Health
Cardinal Health has promoted George Fotiades to the newly-created position of president and chief operating officer.
Archives for February 4, 2004
Sandoz launches into cell culture synthesis
Novartis' generic drugs subsidiary Sandoz has opened two new manufacturing plants in Austria and Slovenia that mark its entry into the contract manufacture of biopharmaceuticals using mammalian cell culture.
FMC deal worth up to $160m, says BioProgress
Tablet-coating specialist BioProgress formalised its agreement with US chemicals and machinery group FMC in deal that could be worth up to $160 million (€128m) in revenues in the first six years.